Med-Ally opening new South Carolina manufacturing plant, creating 90 jobs

Neuromodulation device company Med-Ally is expanding in South Carolina with a new 10,000-square-foot facility in the Charleston, S.C. area. The $2.38 million investment is expected to create 90 new jobs, according to the South Carolina Department of Commerce. The facility will be located at the Charleston International Manufacturing Center in Goose Creek, S.C. It’s expected to

The top 10 medical disruptors of 2018

Each year the Cleveland Clinic determines what the top 10 disruptors in healthcare will be for the following year. The criteria to be considered a disruptor is that it has to be so innovative that it could change healthcare in a significant way in the next year. Approximately 150 to 200 Cleveland Clinic physicians from

Pages: 1 2 3 4 5 6 7 8 9 10 11

7 ways neurostimulation could make our lives better

Neurostimulation is being used for a lot of different things that go beyond motor disorders and diseases. Neurostimulation is used to stimulate certain parts of the brain’s nervous system. It can be invasive with implants or it can be non-invasive with electrode-filled caps and ear clips. The neurostimulation market was worth an estimated $1.9 billion

Pages: 1 2 3 4 5 6 7 8

Noninvasive neuromodulation device to get tested in France

PathMaker Neurosystems announced this week that it has established a research relationship with the Brain and Spine Institute (Institut du Cerveau et de la Moelle Epinière, or ICM) at the Pitié-Salpêtrière Hospital in Paris. The institute will carry out the clinical trials that PathMaker needs to achieve CE Mark for its MyoRegulator system. Boston-based PathMaker boasts that